This inventor holds 2 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Schering Corporation. Active years: 2009.
Location History:
- Marseille, FR (2009)
- Marseilles, FR (2009)
Company Filing History:
2 out of 1,853 
2 out of 1,829 
Years Active: 2009
Title: The Innovative Contributions of Daniel Birnbaum
Introduction
Daniel Birnbaum is a notable inventor based in Marseille, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and reagents related to mammalian FLT3 ligands. With a total of 2 patents, his work has implications for diagnostics and therapeutic applications.
Latest Patents
Birnbaum's latest patents include innovative methods and reagents for binding purified mammalian FLT3 ligands. The first patent focuses on the Flt3 ligand from a mammal, detailing reagents such as purified proteins, specific antibodies, and nucleic acids encoding the ligand. Additionally, it provides methods for using these reagents and diagnostic kits. The second patent also addresses purified mammalian Flt3 ligands, agonists, and antagonists, again emphasizing the importance of specific antibodies and nucleic acids. Both patents highlight the potential for significant advancements in medical diagnostics and treatment.
Career Highlights
Throughout his career, Daniel Birnbaum has worked with esteemed organizations such as the National Institute of Health and Medical Research and Schering Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Charles H. Hannum and Janice A. Culpepper. Their collaborative efforts have further enhanced the impact of Birnbaum's inventions in the scientific community.
Conclusion
Daniel Birnbaum's innovative work in the field of biotechnology, particularly with FLT3 ligands, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving diagnostic and therapeutic methods.